Lifetime costs of alcohol consumption in Thailand: protocol for an incidence-based cost-of-illness study using Markov model

被引:0
|
作者
Luangsinsiri, Chaisiri [1 ,2 ]
Thavorncharoensap, Montarat [3 ,4 ]
Chaikledkaew, Usa [3 ,4 ]
Pattanaprateep, Oraluck [5 ]
Sornpaisarn, Bundit [2 ,6 ]
Rehm, Jurgen [2 ,6 ]
机构
[1] Mahidol Univ, Fac Pharm, Dept Pharm, Philosophy Program Social Econ & Adm Pharm, Bangkok, Thailand
[2] Inst Mental Hlth Policy Res, Ctr Addict & Mental Hlth, Toronto, ON, Canada
[3] Mahidol Univ, Fac Pharm, Dept Pharm, Social & Adm Pharm Excellence Res SAPER Unit, Bangkok, Thailand
[4] Mahidol Univ Hlth Technol Assessment MUHTA, Int Grad Program, Mahidol Univ, Bangkok, Thailand
[5] Mahidol Univ, Fac Med, Dept Clin Epidemiol & Biostat, Ramathibodi Hosp, Bangkok, Thailand
[6] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
来源
BMJ OPEN | 2024年 / 14卷 / 04期
关键词
HEALTH ECONOMICS; Economics; Ethanol; Risk Factors;
D O I
10.1136/bmjopen-2023-079829
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Several prevalence-based cost-of-illness (COI) studies have been conducted to estimate the economic burden of alcohol consumption borne by a particular society in a given year. Yet there are few studies examining the economic costs incurred by an individual drinker over his/her lifetime. Thus, this study aims to estimate the costs incurred by an individual drinker's alcohol consumption over his or her lifetime in Thailand. Methods and analysis An incidence-based COI approach will be employed. To project individuals' associated costs over a lifetime, a Markov modelling technique will be used. The following six alcohol-related diseases/conditions will be considered in the model: hypertension, haemorrhagic stroke, liver cirrhosis, liver cancer, alcohol use disorders and road injury. The analysis will cover both direct (ie, direct healthcare cost, costs of property damage due to road traffic accidents) and indirect costs (ie, productivity loss due to premature mortality and hospital-related absenteeism). The human capital approach will be adopted to estimate the cost of productivity loss. All costs will be presented in Thai baht, 2022. Ethics and dissemination The Institutional Review Board of Mahidol University, Faculty of Dentistry/Faculty of Pharmacy has confirmed that no ethical approval is required (COE.No.MU-DT/PY-IRB 2021/010.0605). Dissemination of the study findings will be carried out through peer-reviewed publications, conferences and engagement with policy-makers and public health stakeholders.
引用
收藏
页数:6
相关论文
共 25 条
  • [1] Societal costs of chemotherapy in the UK: an incidence-based cost-of-illness model for early breast cancer
    Parsekar, Krishnali
    Howard Wilsher, Stephanie
    Sweeting, Anna
    Patel, Anita
    Fordham, Richard
    BMJ OPEN, 2021, 11 (01): : e039412
  • [2] INCIDENCE-BASED COST-OF-ILLNESS MODEL FOR METASTATIC BREAST CANCER IN THE UNITED STATES
    Sorensen, Sonja V.
    Goh, Jo Wern
    Pan, Feng
    Chen, Connie
    Yardley, Denise
    Martin, Miguel
    Knopf, Kevin
    Benedict, Agnes
    Giorgetti, Carla
    Iyer, Shrividya
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2012, 28 (01) : 12 - 21
  • [3] Economic costs of obesity in Thailand: a retrospective cost-of-illness study
    Paiboon Pitayatienanan
    Rukmanee Butchon
    Jomkwan Yothasamut
    Wichai Aekplakorn
    Yot Teerawattananon
    Naeti Suksomboon
    Montarat Thavorncharoensap
    BMC Health Services Research, 14
  • [4] Economic costs of obesity in Thailand: a retrospective cost-of-illness study
    Pitayatienanan, Paiboon
    Butchon, Rukmanee
    Yothasamut, Jomkwan
    Aekplakorn, Wichai
    Teerawattananon, Yot
    Suksomboon, Naeti
    Thavorncharoensap, Montarat
    BMC HEALTH SERVICES RESEARCH, 2014, 14
  • [5] Cost of Schizophrenia to UK SocietyAn Incidence-Based Cost-of-Illness Model for the First 5 Years Following Diagnosis
    Julian Guest
    Ron F. Cookson
    PharmacoEconomics, 1999, 15 : 597 - 610
  • [6] Cost of schizophrenia to UK society - An incidence-based cost-of-illness model for the first 5 years following diagnosis
    Guest, JF
    Cookson, RF
    PHARMACOECONOMICS, 1999, 15 (06) : 597 - 610
  • [7] Cost-of-illness study of hip fracture among Korean elderly women: Incidence-based approach
    Kang, S. H.
    Park, S.
    Kang, D. R.
    Kim, J. Y.
    Chang, Y. H.
    Choi, W. J.
    Moon, S. H.
    Yang, K. H.
    Park, J. Y.
    Kwon, S. Y.
    VALUE IN HEALTH, 2007, 10 (06) : A396 - A396
  • [8] Direct Medical Cost of Hospitalization for Acute Stroke in Lebanon: A Prospective Incidence-Based Multicenter Cost-of-Illness Study
    Abdo, Rachel R.
    Abboud, Halim M.
    Salameh, Pascale G.
    Jomaa, Najo A.
    Rizk, Rana G.
    Hosseini, Hassan H.
    INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING, 2018, 55
  • [9] Clinical and Economic Burden of Valley Fever in Arizona: An Incidence-Based Cost-of-Illness Analysis
    Grizzle, Amy J.
    Wilson, Leslie
    Nix, David E.
    Galgiani, John N.
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (02):
  • [10] DIRECT COST OF SCHIZOPHRENIA IN QUEBEC, CANADA: AN INCIDENCE-BASED MICROSIMULATION MONTE-CARLO MARKOV MODEL
    Dragomir, A.
    Tarride, J. E.
    Angers, J. F.
    Joober, R.
    Rouleau, G.
    Perreault, S.
    VALUE IN HEALTH, 2011, 14 (07) : A291 - A291